As part of our continual presence in Washington, DC, and around the United States, whenever appropriate IFFGD offers testimony to the U.S. Food and Drug Administration (FDA) and other regulatory agencies. Through either written or in-person statements, we share the perspective of functional gastrointestinal (GI) and motility disorder patients. We urge consideration of the patient perspective in regulatory decisions and encourage additional resources to help meet their needs.
IFFGD President and Co-Founder, Nancy J. Norton submitted the following written statement on October 25, 2012 to the Food and Drug Administration Division of Dockets
IFFGD Vice-President, William Norton, submitted the following written public testimony to the FDA in connection with an October 16, 2012 meeting of the Gastrointestinal Drugs
IFFGD Vice-President, William Norton, submitted the following written public testimony to the FDA in connection with a January 11, 2012 meeting of the Gastroenterology and
On December 2, 2010, Dane Christiansen provided the following testimony on behalf of IFFGD members to the Gastroenterology and Urology Devices Panel of the Medical
On April 23, 2002, IFFGD Founder and President, Nancy J. Norton presented the following testimony on behalf of IFFGD members to the Center for Drug
IFFGD sent the following written comments to the FDA in connection with a November 9, 2000 meeting of the Food and Drug Administration (FDA) Gastrointestinal
IFFGD Founder and President Nancy Norton presented the following testimony on behalf of IFFGD members at a June 27, 2000 Center for Drug Evaluation and
On June 26, 2000, IFFGD Founder and President Nancy J. Norton presented the following testimony on behalf of IFFGD members to the Center for Drug
This information is in no way intended to replace the guidance of your doctor.
We advise seeing a physician whenever a health problem arises requiring an expert’s care.
© Copyright 2024 International Foundation for Gastrointestinal Disorders, Inc. (IFFGD).
All Rights Reserved.
Keep up-to-date on the latest news, stories, tips, research highlights, and more!
